Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cell-based vaccination against cancer.

Hiroaki Saito1, Davor Frleta, Peter Dubsky

  • 1Baylor Institute for Immunology Research, Dallas, TX 75204, USA.

Hematology/Oncology Clinics of North America
|June 10, 2006
PubMed
Summary

Vaccination strategies are advancing, but chronic infections like cancer, tuberculosis, malaria, and HIV remain challenging. Dendritic cell vaccines show promise for inducing protective immunity against cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interplay of procoagulatory and neutrophil-derived anticoagulatory proteins in C1q-NET-driven blood coagulation.

Blood·2025
Same author

Peripheral human red blood cell development in human immune system mouse model with heme oxygenase-1 deficiency.

Blood advances·2024
Same author

Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice.

Disease models & mechanisms·2023
Same author

Human CD4 cytotoxic T lymphocytes mediate potent tumor control in humanized immune system mice.

Communications biology·2023
Same author

Spontaneous tumor regression mediated by human T cells in a humanized immune system mouse model.

Communications biology·2023
Same author

IL-6-GP130 signaling protects human hepatocytes against lipid droplet accumulation in humanized liver models.

Science advances·2023

Area of Science:

  • Immunology
  • Vaccinology
  • Cancer Research

Background:

  • Vaccination successes against infectious agents are notable, yet many diseases, including chronic infections like tuberculosis, malaria, and HIV, evade immune responses.
  • Cancer, a chronic disease, also presents challenges for effective vaccination strategies.
  • Dendritic cells (DCs) are crucial regulators of cellular and humoral immunity, making them promising candidates for vaccine development.

Purpose of the Study:

  • To explore the potential of dendritic cells (DCs) in developing effective vaccines against chronic diseases, particularly cancer.
  • To highlight the need for a deeper understanding of DC-mediated immune regulation for optimizing vaccine design.

Main Methods:

  • Review of immunological principles underlying vaccination and immune regulation.

Related Experiment Videos

  • Analysis of the role of dendritic cells in modulating immune responses.
  • Examination of existing data on the immunogenicity of DC-based cancer vaccines in patients.

    • Main Results:

    • Dendritic cells demonstrate a capacity to regulate both cellular and humoral immunity.
    • Antigens delivered via dendritic cells have shown immunogenicity in cancer patients.
    • Further understanding of DC immune regulation is key to enhancing vaccine efficacy.

    Conclusions:

    • Rational vaccine design, informed by a deeper understanding of immunology, is crucial for overcoming challenges posed by chronic infections and cancer.
    • Dendritic cells hold significant potential as vaccine platforms for inducing protective immunity against cancer.
    • Exploiting the regulatory functions of dendritic cells can lead to improved cancer vaccine strategies.